TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 213 filers reported holding TURNING POINT THERAPEUTICS I in Q2 2022. The put-call ratio across all filers is 3.08 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $22,140,000 | +1199.3% | 294,218 | +363.6% | 0.01% | – |
Q1 2022 | $1,704,000 | -84.1% | 63,460 | -71.8% | 0.00% | – |
Q4 2021 | $10,726,000 | +269.6% | 224,840 | +414.7% | 0.00% | – |
Q3 2021 | $2,902,000 | -41.0% | 43,686 | -30.7% | 0.00% | – |
Q2 2021 | $4,918,000 | +14.6% | 63,040 | +38.9% | 0.00% | – |
Q1 2021 | $4,292,000 | -63.4% | 45,369 | -52.9% | 0.00% | -100.0% |
Q4 2020 | $11,728,000 | +190.9% | 96,244 | +108.5% | 0.00% | – |
Q3 2020 | $4,032,000 | +254.3% | 46,152 | +161.9% | 0.00% | – |
Q2 2020 | $1,138,000 | -79.0% | 17,625 | -85.5% | 0.00% | -100.0% |
Q1 2020 | $5,421,000 | +684.5% | 121,405 | +994.2% | 0.00% | – |
Q4 2019 | $691,000 | +62.6% | 11,095 | -1.8% | 0.00% | – |
Q3 2019 | $425,000 | – | 11,300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Cormorant Asset Management, LP | 2,392,297 | $291,501,000 | 6.94% |
Burrage Capital Management LLC | 72,484 | $8,832,000 | 6.73% |
MPM BioImpact LLC | 617,372 | $75,226,000 | 6.50% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 113,541 | $13,816,000 | 3.77% |
Orbimed Advisors | 2,745,327 | $334,518,000 | 2.93% |
SECTORAL ASSET MANAGEMENT INC | 257,379 | $31,362,000 | 2.21% |
Parkman Healthcare Partners LLC | 59,377 | $7,235,000 | 1.85% |
Nicholas Investment Partners, LP | 183,676 | $22,381,000 | 1.73% |
EMERALD ADVISERS, LLC | 357,038 | $43,505,000 | 1.44% |
EMERALD MUTUAL FUND ADVISERS TRUST | 336,173 | $40,963,000 | 1.42% |